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TDP-43 stabilises the processing 
intermediates of mitochondrial 
transcripts
Keiichi Izumikawa1,2, Yuko Nobe2,3, Harunori Yoshikawa  1,2,4, Hideaki Ishikawa1,2, Yutaka 
Miura1, Hiroshi Nakayama5, Takashi Nonaka6, Masato Hasegawa6, Naohiro Egawa7, Haruhisa 
Inoue  7, Kouki Nishikawa8, Koji Yamano9, Richard J. Simpson1,10, Masato Taoka2,3, Yoshio 
Yamauchi2,3, Toshiaki Isobe2,3 & Nobuhiro Takahashi1,2
The 43-kDa trans-activating response region DNA-binding protein 43 (TDP-43) is a product of a 
causative gene for amyotrophic lateral sclerosis (ALS). Despite of accumulating evidence that 
mitochondrial dysfunction underlies the pathogenesis of TDP-43–related ALS, the roles of wild-type 
TDP-43 in mitochondria are unknown. Here, we show that the small TDP-43 population present in 
mitochondria binds directly to a subset of mitochondrial tRNAs and precursor RNA encoded in L-strand 
mtDNA. Upregulated expression of TDP-43 stabilised the processing intermediates of mitochondrial 
polycistronic transcripts and their products including the components of electron transport and 16S mt-
rRNA, similar to the phenotype observed in cells deficient for mitochondrial RNase P. Conversely, TDP-
43 deficiency reduced the population of processing intermediates and impaired mitochondrial function. 
We propose that TDP-43 has a novel role in maintaining mitochondrial homeostasis by regulating the 
processing of mitochondrial transcripts.
The trans-activating response region DNA-binding protein 43 (TDP-43) is a member of the family of hetero-
geneous nuclear ribonucleoproteins and contains two highly conserved RNA recognition motifs (RRMs) and a 
non-conserved C-terminal region that mediates protein-protein interactions1. TDP-43 binds tightly the (UG)n 
motif1–4 and helps regulate several aspects of mRNA biogenesis including transcription, pre-mRNA splicing and 
export, and mRNA stability2, 4, 5. TDP-43 is one of the causative gene products of amyotrophic lateral sclerosis 
(ALS) that is an adult-onset neurodegenerative disorder characterised by progressive degeneration of upper and 
lower motor neurons6, 7. The majority of TDP-43 mutations that cause ALS are found in the C-terminal region, 
although some are found in the RRMs8–10. ALS mutant TDP-43 proteins, including those with mutation of the 
RRMs have an increased half-life in cell models9, 11, 12.
Although TDP-43 shuttles between the nucleus and the cytoplasm, it mainly resides in the nucleus under 
physiological conditions13. TDP-43 is cleared from the nuclear compartment and is incorporated into cytoplasmic 
ubiquitinated and/or hyperphosphorylated inclusions in patients with familial or sporadic ALS and in patients 
with frontotemporal lobar degeneration6, 14–16. Several animal models over-expressing wild type TDP-43 leads 
to neurodegeneration similar to that observed in ALS17–24, accumulate mitochondria in cytoplasmic inclusions 
in motor neurons23, lack mitochondria in motor axon terminals24, or have abnormal juxtanuclear aggregates 
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of mitochondria in spinal motor neurons22, suggesting that wild type TDP-43 affects mitochondrial function. 
Supporting this, TDP-43 localises to mitochondria of NSC34 cells, a hybrid cell line that has several motor neu-
ron features25. TDP-43–induced cytotoxicity also strongly correlates with mitochondrial functions, including 
respiratory capacity and respiratory chain activity, in yeast cells expressing human TDP-4326. In addition, TDP-
43 co-localises with mitochondria in motor neurons, and ALS-associated mutants enhance its localisation in 
mitochondria27, 28. The enhanced localisation of mutant TDP-43 to mitochondria also disrupts mitochondrial 
dynamics and function27, 28. The mitochondrial fusion protein mitofusin 2 (Mfn2) has also been demonstrated 
to be involved in mitochondrial impairment, but the functional relationship between TDP-43 and Mfn2 is 
unknown27. In this regard, TDP-43 mutants also disrupt the vesicle-associated membrane protein-associated 
protein B (VAPB)– protein tyrosine phosphatase-interacting protein-51 (PTPIP51) interaction and cellular Ca2+ 
homeostasis, which disrupts mitochondria–endoplasmic reticulum interactions that are implicated in several 
physiological processes including ATP production, mitochondrial biogenesis, and apoptosis29; however, TDP-
43 is involved only indirectly in these processes through its ability to activate glycogen synthase kinase-3β29. In 
addition, it was recently proposed that TDP-43 and its mutants impair the assembly of electron transfer complex I 
by binding to mitochondrial mRNAs encoding NADH-ubiquinone oxidoreductase chain 3 (ND3) and ND6 and 
inhibiting their translation28. Despite the obvious involvement of TDP-43 in mitochondrial function, the direct 
mitochondrial target of TDP-43 remains elusive.
Results
TDP-43 binds mitochondrial (mt-) tRNAAsn, mt-tRNAGln and mt-tRNAPro directly in vivo. Given 
that TDP-43 contains RNA recognition motifs (RRMs), we first investigated the association of RNA with exog-
enously expressed TDP-43 using mass spectrometry (MS) and the Ariadne search engine30–32. We established 
human Flp-InTM T-RExTM 293 (T-REx 293) cell line expressing doxycycline-inducible wild-type human TDP-43 
carrying a triple affinity-purification tag (DAP-tag: 6 × histidine, biotin, and FLAG; Supplementary Fig. 1a), and 
showed that the DAP-TDP-43 expression reduced the level of endogenous TDP-43, suggesting that the exoge-
nous DAP-TDP-43 is behaved as native TDP-43 by constitutive negative feedback mechanism (Supplementary 
Fig. 1b)4. We pulled down TDP-43–associated RNAs and detected ~70-nt RNAs by denaturing urea-PAGE 
(Fig. 1a). The MS-based identification method revealed that the mitochondrial (mt) genome regions encod-
ing mt-tRNAAsn, mt-tRNAGln, and mt-tRNAPro matched very well with our RNase T1–digested oligonucleotide 
fragments (Fig. 1b and Supplementary Table 1). These three mt-tRNAs were also detected by northern blotting 
(Supplementary Fig. 1c) and are encoded in the L-strand of mtDNA. We confirmed the association of endoge-
nous TDP-43 with these mt-tRNAs using anti-TDP-43 immunoprecipitation (Fig. 1c), and the interactions were 
determined to occur directly within intact cells as assessed with UV cross-linking in vivo and immunoprecipi-
tation (Fig. 1d). To determine the region of TDP-43 responsible for the binding with the mt-tRNAs, we estab-
lished T-REx 293 cell lines expressing TDP-43 mutants that had a domain defect (ΔRRM1, ΔRRM2, ΔGR, 
Δ315), a point mutation at amino acid residue 136, 140 or 145, or double mutations at residues 147 and 149 
(Supplementary Fig. 1d), and showed that residues K136, K145, and F147/149 in the TDP-43 RRM1 are crit-
ical for the interaction of TDP-43 with mt-tRNAAsn and mt-tRNAGln (Supplementary Fig. 1e and Fig. 1e). We 
also utilised recombinant TDP-43 and synthesised five mt-tRNAAsn mutants in which nucleotide (nt) sequence 
replacements were made corresponding to a specific region of mt-tRNALeu [Ac-stem(Leu), D-loop(Leu), 
pAntiCdn(Leu), Var-R(Leu), or T-loop(Leu)] as well as mt-tRNALeu as a negative control (Supplementary Fig. 1f). 
An electrophoretic mobility shift assay revealed that recombinant TDP-43 binds mt-tRNAAsn but not mt-tRNALeu 
(Supplementary Fig. 1g) and that the region corresponding to UGUUU (nt 44–48) of mt-tRNAAsn is required for 
interaction with TDP-43 (Supplementary Fig. 1f and Fig. 1f). Competitive interaction analysis using synthetic 
RNAs (sRNA-1, sRNA-2, sRNA-3, sRNA-4, and sRNA-5, Fig. 1g) suggested that an additional sequence GUGG 
(nt 49–53) in mt-tRNAAsn is required for inhibiting the binding to TDP-43 (Fig. 1g).
TDP-43 is localised in mitochondria in T-REx 293 cells. To assess localisation of TDP-43 in mitochon-
dria further, we treated a mitochondrial fraction with proteinase K and detected both endogenous and exoge-
nous TDP-43; TDP-43 was not detected, however, if the mitochondrial membrane was permeabilised with Triton 
X-100 prior to proteinase K treatment (Fig. 2a). Furthermore, we detected endogenous TDP-43 in mitochondria 
by immunoelectron microscopy (Fig. 2b). Taken together, these data indicated that TDP-43 has the ability to 
associate directly with mt-tRNAAsn, mt-tRNAGln, and mt-tRNAPro present within the mitochondria of T-REx 293 
cells.
TDP-43 stabilises not only the cellular levels of the TDP-43-bound mt-tRNAs but also that of 
TDP-43-unbound mt-tRNA. In human mitochondria, large polycistronic RNA transcripts are generated 
from the L- and H-strand promoters of mtDNA33. The L-strand encodes one oxidative phosphorylation system 
subunit (ND6) and eight mt-tRNAs (for Pro, Glu, Ser (UCN), Tyr, Cys, Asn, Ala, and Gln) (Supplementary 
Fig. 2a). Of these, the mt-tRNAs for Asn, Gln, and Pro bound directly to TDP-43. To gain insight into the phys-
iological roles of the binding of TDP-43 to the L-strand-encoded mt-tRNAs, we examined whether TDP-43 
is involved in stabilisation of those three mt-tRNAs via direct binding. We used ethidium bromide (EtBr) to 
inhibit mtDNA transcription and first examined the effect of EtBr on stability of L-strand coded mt-RNAs in 
T-REx 293 cells. EtBr reduced the levels of all of the L-strand-encoded mt-tRNAs with time but it did not affect 
a genomic tRNAMet (Supplementary Fig. 2b). It also reduced the levels of H-strand-encoded mt-tRNALeu(UUR) 
(Supplementary Fig. 2b) and mRNAs for ND1, ND2 and COXI, whereas it did not affect that of 28S rRNA 
(Supplementary Fig. 2c). We then examined the stabilities of TDP-43–bound mt-tRNAAsn and mt-tRNAGln and 
TDP-43–unbound mt-tRNALeu(UUR) and mt-12S rRNA by inhibiting mtDNA transcription with EtBr before 
and after doxycycline induction of TDP-43. Overexpression of TDP-43 slowed the degradation of mt-tRNAAsn 
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Figure 1. TDP-43 associates with a subset of L-strand-encoded mt-tRNAs. (a) RNAs immunoprecipitated (IP) 
from DAP (double affinity purification tag, see Supplementary Fig. 1a)-TDP-43–expressing cells or T-REx 293 
cells were stained with SYBR Gold. (b) A typical MS/MS spectrum of the oligonucleotide [ADUAGp]2− that 
originated from the RNase T1 digest of mt-tRNAAsn (top) or [AAUUtm5s2UUGp]2− from that of mt-tRNAGln 
(bottom). m/z, mass-to-charge ratio. (c) Endogenous TDP-43 was immunoprecipitated with anti-TDP-43 
(αTDP-43) and analysed by western blotting (WB) with anti-TDP-43. The immunoprecipitated RNAs were 
detected by northern blotting (NB) with the probes indicated on the right. Rabbit IgG served as a negative 
control. (d) DAP-TDP-43 complex was immunoprecipitated from DAP-TDP-43-expressing T-REx 293 cells 
with (+) or without (−) UV crosslinking, separated by SDS-PAGE, and detected by WB with horseradish 
peroxidase (HRP)-conjugated streptavidin (left). The SDS-PAGE gel bands containing RNA-bound DAP-
TDP-43 corresponding to the area indicated as 1 and 2 were excised, and RNAs were extracted from the bands 
and analysed by NB with RNA-specific probes (right). (e) Each DAP-TDP-43 mutant bearing a mutation(s) 
at residue(s) K136, K140, K145, or F147/L149 was immunoprecipitated with anti-FLAG and analysed by 
www.nature.com/scientificreports/
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and mt-tRNAGln (Fig. 3a and b). Moreover, TDP-43 overexpression unexpectedly slowed the degradation of 
mt-tRNALeu(UUR), whereas it had only a negligible effect on the degradation of mt-12S rRNA (Fig. 3b). These 
results suggested that TDP-43 could increase the abundance of particular mt-tRNAs independent of mtDNA 
transcription. Although the stabilisation of mt-tRNAAsn and mt-tRNAGln may be attributable, at least in part, to 
the direct binding of TDP-43, the stabilisation of mt-tRNALeu(UUR) upon overexpression of TDP-43 cannot be 
attributed to stabilisation mediated by direct binding of TDP-43.
TDP-43 stabilises the L-strand-encoded mt-tRNAs and their precursors. We next used northern 
blotting to address whether overexpression of TDP-43 affects cellular levels of L-strand-encoded mt-tRNAs first 
other than those bound by TDP-43, using nuclear genome–encoded RNAs (tRNAMet, U1 snRNA, and 5.8S rRNA) 
as the references. Overexpression of TDP-43 significantly increased the cellular levels of all L-strand-encoded 
mt-tRNAs (Fig. 4a). Consistent with the result described above (Fig. 3b), it also increased the cellular level of 
H-strand-encoded mt-tRNALeu(UUR) (Fig. 4a). In addition, the RNA species detected in the northern blots for 
mt-tRNAAsn, mt-tRNACys, mt-tRNATyr, mt-tRNASer(UCN), and mt-tRNALeu(UUR) appeared slightly larger than the 
mature transcripts upon overexpression of TDP-43 (Fig. 4b). These data suggested that TDP-43 might stabilise 
the production of L-strand-encoded mt-tRNAs and possibly H-strand-encoded mt-tRNAs at the level of their 
precursors or polycistronic RNA transcripts.
To explore this possibility, we next investigated the accumulation of L-strand-encoded polycistronic tran-
scripts in TDP-43–expressing T-REx 293 cells by L-strand-specific reverse-transcription PCR (RT-PCR). 
The RT-PCR primers were designed to amplify the boundaries among mt-tRNAs or between mt-tRNAs and 
mt-mRNAs in the region containing mt-tRNATyr (Y)-mt-tRNAAla (A), the region complementary to COXI 
mRNA (mirrorCOXI)-Y, mirrorND2-mt-tRNAGln (Q), and mirrorCYB-mt-tRNAGlu (E) to test for cleavage 
within these boundary regions. All boundaries were found to increase in abundance with time after doxycycline 
induction compared with GAPDH mRNA (Fig. 4c). In addition, we used a synthetic precursor RNA encom-
passing a region containing mirrorCOXI and mt-tRNATyr-mt-tRNACys-mt-tRNAAsn-mt-tRNAAla (YCNA) and 
confirmed the direct binding of the precursor RNA to recombinant TDP-43 (Fig. 4d) and the stabilisation of 
the precursor RNA by recombinant TDP-43 in mitochondrial extracts (Fig. 4e). These results suggested that 
increased expression of TDP-43 stabilises the mt-tRNA-containing regions of mitochondrial polycistronic tran-
scripts and increases the abundance of their processed products. Thus, TDP-43 appears to participate in the stabi-
lisation of large polycistronic transcripts from L-strand mtDNA and regulates the cellular levels of the precursor 
and processed mt-tRNA products.
Overexpression of TDP-43 increases un-processed precursors that are accumulated by the 
deficiency of mitochondrial RNase P. Given that TDP-43 overexpression increased H-strand–encoded 
mt-tRNALeu(UUR) (Fig. 4a,b), we also examined whether overexpression of TDP-43 could stabilise H-strand poly-
cistronic transcripts. The H-strand of mtDNA encodes 10 mt-mRNAs for 12 oxidative phosphorylation system 
subunits (ND1, ND2, COXI, COXII, ATP8-ATP6 (bicistronic), COXIII, ND3, ND4L-ND4 (bicistronic), ND5, 
and CYB), 2 mt- rRNAs (12S and 16S), and 14 mt-tRNAs (for Phe, Val, Leu (UUR), Ile, Met, Trp, Asp, Lys, Gly, 
Arg, His, Ser (AGN), Leu (CUN), and Thr) (Supplementary Fig. 2a). To detect transcripts from H-strand mtDNA, 
we used nine probes for northern blotting (Fig. 5a) and showed that TDP-43 overexpression increased minimally 
three RNA fragments; those corresponding to 16S-mirrorQ (expected to be 2730 nt, detected by probes 1–4 in 
Fig. 5a), W-COXII (expected to be 2758 nt, detected by probes 6–9 in Fig. 5a) and mirrorANCY-COXI (expected 
to have 1859 nt, detected by probes 7 and 8 in Fig. 5a) (Fig. 5b and c). RT-PCR analysis detected an increase in 
transcripts containing the boundaries between ND2 mRNA and mirrorN, and mirrorA and COXI mRNA upon 
overexpression of TDP-43 (Supplementary Fig. 3a), supporting accumulation of mirrorANCY-COXI and addi-
tional ND2-mirrorN fragments in the presence of excess TDP-43. In addition, mt-mRNA quantification using 
RT-qPCR normalised to GAPDH mRNA revealed that TDP-43 overexpression increased transcripts of many of 
the mt-mRNAs (Supplementary Fig. 3b). Collectively, these data suggested that the increased levels of TDP-43 
stabilises at least the region encompassing 16S rRNA to COXII mRNA of H-strand transcripts.
Two RNase activities are required for proper mt-tRNA and mt-mRNA maturation: mitochondrial RNase P 
(MRPP3)-mediated cleavage of precursor molecules at the 5′ end, and tRNase Z (ELAC2)-mediated cleavage at 
the 3′ end34. Therefore, accumulation of large precursor transcripts was also investigated by northern blotting after 
knockdown of MRPP3 or ELAC2 (Supplementary Fig. 3c and d). The analyses revealed that short interfering RNA 
(siRNA)-mediated knockdown of MRPP3 but not that of ELAC2 resulted in the accumulation of processing inter-
mediates corresponding to 16S-mirrorQ (detected by probes 1–3), ND1-mirrorQ (detected by probes 3 and 4), 
and W-COXII (detected by probes 6–9) relative to 28S rRNA staining compared with a mock knockdown with a 
sequence-scrambled RNA (scRNA; Supplementary Fig. 3d). All these processing intermediates accumulated in 
WB with HRP-conjugated streptavidin or by NB with the probes indicated on the right. 5S rRNA served as a 
loading control for RNA and was detected using SYBR Gold staining. (f) Recombinant trigger factor–fused 
TDP-43 (TF-TDP-43) was mixed with synthesised mt-tRNAAsn or its mutant [Ac-stem(Leu), D-loop(Leu), 
pAntiCdn(Leu), Var-R(Leu) or T-loop(Leu)] shown in Supplementary Fig. 1f, and analysed by electrophoretic 
mobility shift assay. tRNAs were detected by NB with probes indicated on the left. (g) Top: RNAs were 
immunoprecipitated from TDP-43–expressing T-REx 293 cells in the absence (NT) or presence of synthetic 
RNA (sRNA-1, sRNA-2, sRNA-3, sRNA-4, or sRNA-5) and analysed by NB with probes indicated on the 
right. T-REx 293 cells (TR) served as a negative control. Bottom: Sequences of the synthetic RNAs. Asterisks 
correspond to the sequence that was replaced in Var-R(Leu).
www.nature.com/scientificreports/
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the TDP-43-overexpressing cells (Fig. 5a–c). Thus, the phenotype observed with mitochondrial RNase P defi-
ciency is similar to that observed upon overexpression of TDP-43.
Overexpression of TDP-43 causes mitochondrial dysfunction. Concurrent with the accumulation of 
processing intermediates, overexpression of TDP-43 in T-REx 293 cells caused irregular staining of mitochondria 
(Fig. 6a) and led to an increase in amount of reactive oxygen species in cells over time after doxycycline induc-
tion (Fig. 6b). Accordingly, TDP-43 overexpression inhibited cell proliferation, whereas the TDP-43 mutants 
having reduced ability to bind mt-tRNAAsn and mt-tRNAGln (K136A, K145A, and F147/149L) did not inhibit cell 
proliferation (Fig. 6c). Notably, we also found that inhibition of mitochondrial transcription with EtBr abolished 
the inhibitory effect of excess TDP-43 expression on cell proliferation (Fig. 6d). A previous report demonstrated 
that the defects in the processing of mt-tRNA precursors impair the translation of mtRNAs35, 36. To examine 
whether the cellular level of TDP-43 affects this translation, we estimated the levels of mitochondrial proteins in 
TDP-43–overexpressing cells and found apparently reduced levels of a number of proteins including ND2, ND5, 
CYB, and ATP8 at 24–48 h after doxycycline induction (Fig. 6e,f). These results suggested that TDP-43 overex-
pression deregulates the normal processing of mitochondrial polycistronic transcripts for the production of both 
tRNAs and mitochondrial proteins. Thus, TDP-43–induced cytotoxicity correlated with mitochondrial functions 
in human cells as reported for yeast cells expressing human TDP-4326.
TDP-43 is required for maintaining mitochondrial function. Given the results that TDP-43 affected 
the processing of mitochondrial polycistronic transcripts and the expression of their processing products, we 
used several approaches to determine the function of TDP-43 in mitochondria further. We first examined the 
effects of siRNA-mediated knockdown of TDP-43 on mitochondrial function. TDP-43 knockdown reduced mito-
chondrial membrane potential and the cellular levels of ATP and the enzyme activity of electron transfer complex 
I relative to levels in scRNA-treated cells (Fig. 7a–c). In addition, TDP-43 knockdown caused significant reduc-
tions on 16S-mirrorQ and mirrorN-COXI, as revealed by northern blotting (Fig. 7d). Thus, TDP-43 appears to be 
Figure 2. TDP-43 is localised in mitochondria in T-REx 293 cells. (a) Mitochondria prepared from T-REx 293 
cells (T-REx 293 MT) or DAP-TDP-43 expressing T-REx 293 cells (TDP-43 MT) were treated with proteinase K 
(PK) in the presence (+) or absence (−) of Triton X-100 (TX-100). Proteins present in the outer mitochondrial 
membrane (OMM), inner membrane (IMM), or matrix were detected by WB with antibodies indicated on the 
right. Open arrowhead and closed arrowhead indicate DAP-TDP-43 and endogenous TDP-43, respectively. 
TCL; Total cell lysate. (b) Endogenous TDP-43 was detected within mitochondria of T-REx 293 cells by 
immunoelectron microscopy using anti-TDP-43 (60019-2-Ig). Open arrowheads indicate stained TDP-43. N, 
nucleus; mt, mitochondria.
www.nature.com/scientificreports/
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Figure 3. TDP-43 overexpressed increases stabilities of mt-tRNAAsn, mt-tRNAGln, and mt-tRNALeu(UUR). DAP-
TDP-43–inducible T-REx 293 cells were treated with or without doxycycline (Dox) for 24 h and then treated 
with EtBr for the indicated periods. Cells were collected at 0, 6, 10, and 24 h after addition of EtBr for analysis 
of mt-tRNAAsn by northern blotting (a) and at 0, 10, 24, 36 h for analysis of mt-tRNAGln or mt-tRNALeu(UUR) (b). 
mt-12S rRNA was detected by SYBR Gold staining and MS-based analysis (b). The graphs present data for the 
average ± SD (three independent experiments) of staining intensities at each time point relative to 0 h. Each 
band intensity was normalised to that of 5S rRNA detected using SYBR Gold staining.
required for maintaining appropriate levels of at least certain mt-tRNAs, mt-mRNAs, and mt-mRNA precursors 
and for maintaining mitochondrial function.
Discussion
In human mtDNA, the genes are located in three different transcription units (one in the L-strand and two in 
the H-strand) that are transcribed to different extents. The one H-strand transcription unit that includes only the 
mt-rDNA region is transcribed most frequently and is responsible for producing the majority of the mt-rRNAs37. 
The product of the other H-strand transcription unit is a polycistronic RNA molecule corresponding to nearly the 
entire length of the H-strand that is a precursor for the majority of mt-tRNAs and mt-mRNAs37. This H-strand 
unit is transcribed at ~4% of the frequency of the H-strand mt-rDNA transcription unit37. On the other hand, 
the L-strand unit is transcribed 10–16 times more frequently than the nearly entire H-strand unit33, 37. Our pres-
ent data suggest that TDP-43 overexpression stabilises at least two regions (corresponding to mt-tRNAPro and 
mt-tRNAAsn/mt-tRNAGln) of this L-strand transcription unit, although we cannot exclude the possibility that 
www.nature.com/scientificreports/
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Figure 4. TDP-43 overexpression increases polycistronic transcripts of L- and H-strand mtDNA. (a) Relative 
band intensities of mt-tRNAs in total RNA extracted from DAP-TDP-43–expressing T-REx 293 cells (harvested at 
0, 24, and 48 h after induction with doxycycline, Dox) were quantified by northern blotting after polyacrylamide 
gel electrophoresis. mt-AAA represents mt-tRNAAAA; e.g., mt-Pro, mt-tRNAPro, etc. 5S rRNA stained with 
SYBR Gold served as the loading control. Data are mean ± SD, n = 3–6. **P < 0.01; *P < 0.05 (paired t test). 
(b) Overexposed views of representative northern blots from (a) showing precursor bands of each mt-tRNA. 
5S rRNA stained with SYBR Gold served as the loading control. (c) Total RNA extracted from DAP-TDP-43–
expressing T-REx 293 cells harvested at 0, 24, or 48 h after Dox induction were reverse transcribed (+RT) or 
not reverse transcribed (−RT) with the indicated gene-specific primers for L-strand-specific RT-PCR analysis. 
The PCR products were separated by PAGE and detected with SYBR Gold staining. The primers amplified the 
following: a 140-nt region in GAPDH mRNA and a 300-nt region of the L-strand transcript containing mt-
tRNATyr, mt-tRNACys, mt-tRNAAsn, and mt-tRNAAla (Y - A, top left), a 400-nt region between mirrorND2 and 
mt-tRNAGln (Q) of the L-strand transcript (bottom left), a 300-nt region between mirrorCOXI and mt-tRNATyr 
(Y) of the L-strand transcript (top right), and a 400-nt region between mirrorCYB and mt-tRNAGlu (E) of the 
L-strand transcript (bottom right). Schematic diagrams of the corresponding PCR fragments are shown (upper 
diagram). (d) Recombinant TDP-43 fused with trigger factor (TF) and FLAG tag (FL) (TF-TDP43-FL) was 
mixed with synthesised mirrorCOXI-YCNA (mt-tRNATyr-mt-tRNACys-mt-tRNAAsn -mt-tRNAAla; 2000 nt) RNA 
www.nature.com/scientificreports/
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the entire L-strand transcript is stabilised by the binding of TDP-43 because the region containing mt-tRNAPro 
is located in the first part of the L-strand mtDNA that is transcribed, and the region containing mt-tRNAAsn/
mt-tRNAGln is located at the 3′ end. It is also likely that TDP-43 binds to regions of mt-transcripts other than the 
regions corresponding to the three mt-tRNAs because of its general RNA-binding properties1, 2. We also propose 
that the increase in the L-strand transcript and/or its processing products induced by TDP-43 overexpression 
may stabilise all or part of the H-strand transcript and/or its processing products through complementary asso-
ciation, resulting in increased levels of these processing products (Fig. 8). Rackham et al.36 recently reported that 
mitochondrial MRPP3 is required for the biogenesis of mitochondrial ribosomal subunits that are produced 
co-transcriptionally on an unprocessed RNA containing the 16S rRNA. Our present data indicate that increased 
expression of TDP-43 causes accumulation of unprocessed RNA containing the 16S rRNA similar to that caused 
by conditional knockout of MRPP336. In addition, the results that increased expression of TDP-43 upregulated 
the levels of mt-transcripts and their products are consistent with those of Rackham et al.36 in that the conditional 
knockdown of MRPP3 enhances the rate of transcription and impairs protein synthesis. Moreover, it is also 
possible that TDP-43 stabilises mt-transcripts and increases the ratio of these to MRPP3, resulting in the accu-
mulation of processing intermediates. Finally, we should note that the unprocessed RNA containing 16S rRNA 
(indicated as 16S-mirrorQ) seems to be corresponded to RNA 19 that is increased in diseases associated with 
mt-tRNALeu(UUR) gene mutations38, 39.
Because TDP-43 strictly controls its own expression through a negative feedback loop in which TDP-43 binds 
to the 3′ untranslated region in its own mRNA4, our findings provide important insight into the physiological 
roles of this negative feedback control and indicate that the strict control of TDP-43 expression is critical for 
maintaining mitochondrial homeostasis. In this context, mutations in TDP-43 that affect its stability or expres-
sion are expected to reduce mitochondrial function. Our present data provides a new mechanism underlying 
disruption of mitochondrial function by TDP-43 that differs from the mechanisms that involve perturbation of 
Mfn227, the VAPB–PTPIP51 interaction29, or translation of ND3 and ND628.
Methods
Immunoprecipitation of DAP-tagged protein associated complex. Confluent cells were washed 
with PBS and suspended in five packed cell volumes of lysis buffer (50 mM Tris-HCl (pH 7.4), 150 mM NaCl, and 
0.5% (w/v) IGEPAL CA-630) containing 2 mM ribonucleoside-vanadyl complex, 1 mM PMSF, 2 µg/ml aprotinin, 
2 µg/ml pepstatin A, and 2 µg/ml leupeptin for 30 min on ice. After removal of any insoluble residue by centrifu-
gation at 20,000 × g for 30 min at 4 °C, the supernatants were used as cell lysate for the following immunoprecipi-
tation. Cell lysate (5 mg) prepared from 2 × 107 cells were incubated with 15 µl of anti-FLAG M2 magnetic beads 
(Sigma-Aldrich) for 2 h at 4 °C. The beads were washed five times with 1 ml of lysis buffer, and proteins and RNA 
were eluted with 150 µl of Protein-RNA extraction buffer (7 M urea, 350 mM NaCl, 1% SDS, 10 mM Tris-HCl (pH 
8.0), 10 mM EDTA, and 2% 2-mercaptoethanol) for 5 min. The eluted proteins and RNA were subjected to SDS-
PAGE or denaturing (8 M) urea PAGE, respectively, as described previously40–42.
In-gel RNA digestion and LC-MS for RNA analysis. In-gel RNA digestion was performed as described 
previously31. LC-MS analysis of RNA, and database search and interpretation of MS/MS spectra of RNA were 
performed as described30, 31, 40, 41.
Northern blot analysis. Total RNA was isolated using the RNAgents Total RNA Isolation System 
(Promega). For analysis of mt-mRNAs, 5 µg of total RNA was subjected to 2% agarose/formaldehyde gel elec-
trophoresis in 3-(N-morpholino)propanesulfonic acid running buffer. For analysis of mt-tRNAs, 1 µg of total 
RNA was subjected to denaturing (8 M) urea PAGE in Tris-borate-EDTA running buffer, stained with SYBR 
Gold (Invitrogen) for 10 min, and visualised using the LAS4000 Luminescent Image Analyzer System (Fujifilm). 
The separated total RNAs were transferred to a Hybond N + membrane (GE Healthcare). The membrane was 
dried and subsequently cross-linked using an ultraviolet cross linker (Funakoshi, Tokyo) at 120 mJ/cm2. For 
mt-mRNAs analysis, the membranes were stained with methylene blue. Hybridizatioin with biotin-labeled DNA 
probes and detection of RNA signals were performed as described previously40, 41. The oligonucleotides used as 
probes are shown in Supplementary Table 2.
UV-CLIP. T-REx 293 cells expressing DAP-TDP-43 were cross-linked by ultraviolet irradiation at 400 mJ/cm2, 
and DAP-TDP-43-associated complexes were immunoprecipitated with anti-FLAG M2 magnetic beads. 
After heating for 5 min at 65 °C in SDS sample buffer, DAP-TDP-43-associated complexes were released from 
the anti-FLAG M2 magnetic beads, and separated by SDS-PAGE using a Bis-Tris gel (Running gel: 360 mM 
Bis-Tis-HCl (pH 6.8), 8% acrylamide, 0.1% tetramethylethylenediamine, 1% ammonium persulfate; Stacking 
gel: 360 mM Bis-Tis-HCl (pH6.8), 5% acrylamide, 0.1% tetramethylethylenediamine, 1% ammonium persulfate) 
and Bis-Tris running buffer (50 mM Tris, 50 mM 3-(N-morpholino)propanesulfonic acid, 5 mM EDTA, 0.5% 
SDS). The separated proteins were electrophoretically transferred to a Protran BA 85 Nitrocellulose membrane 
(Whatman, Maidstone, UK). The membrane was blocked with 5% non-fat dried skim milk in TBST for 30 min, 
washed with TBST, and then incubated with HRP-conjugated streptavidin (Thermo Fisher Scientific, San Jose, 
and pulled down with anti-FLAG beads. mirrorCOXI-YCNA was detected by northern blotting, and TF-FL or 
TF-TDP43-FL by western blotting with anti-FLAG. (e) mirrorCOXI-YCNA was incubated with mitochondrial 
extract from 293 T cells for the indicated times in the presence of TF-FL or TF-TDP43-FL. TFAM (transcription 
factor A mitochondrial protein) served as a loading control. Data in the graph represent the mean ± SEM of three 
independent experiments.
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CA) for 30 min. After washing three times with TBST for 10 min, the Chemiluminescent Nucleic Acid Detection 
Module kit (Thermo Fisher Scientific) was used for detecting biotin of DAP-TDP-43. Stained parts of the membrane 
were excised and incubated in 250 µl of Proteinase K buffer (10 mM Tris-HCl pH 8.0, 30 mM NaCl, 10 mM EDTA, 
2 mg/ml Proteinase K) at 37 °C for 30 min. After addition of 250 µl of Protein-RNA extraction buffer, RNA was iso-
lated by phenol-chloroform extraction and isopropanol precipitation and subjected to northern blot analysis.
Figure 5. TDP-43 overexpression causes accumulation of intermediates of mitochondrial transcript. (a) 
Schematic diagram of H-strand mitochondrial DNA from mt-tRNAPhe (F) to ATP6, and the corresponding 
mt-transcripts are shown. Nine probes used for northern blotting are indicated above the diagram. (b) Total 
RNA extracted from DAP-TDP-43-expressing T-REx 293 cells harvested at 0, 24, or 48 h after doxycycline 
(Dox) induction were analysed by northern blotting with the probes indicated under the figures. EtBr served as 
a negative control for the mt-transcripts. The processing intermediates of mt-transcripts identified by northern 
blotting are indicated under the diagram and to the right of each panel. (c), Graphical representation of band 
intensities for the observed mt-transcripts shown in a relative to cells without Dox induction (0 h). Data are the 
average ± SEM of at least three independent experiments. **P < 0.01; *P < 0.05 (paired t test).
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RNA Synthesis by in vitro transcription. The template DNAs for in vitro transcription of mt-tRNA(Asn), 
AC-stem(Leu), D-Loop(Leu), pAntiCdn(Leu), Var-R(Leu), T-Loop(Leu), and Leu(UUR) RNA were generated 
by annealing the primer sets shown in Supplementary table 2, respectively. In vitro transcription was performed 
with 0.2 pmol of the template DNA using CUGA® 7 in vitro transcription kit (NIPPON GENE) according to 
Figure 6. TDP-43 overexpression impairs mitochondrial function. (a) Exogenous TDP-43 was detected 
in DAP-TDP-43–expressing T-REx 293 cells by immunocytochemical analysis with anti-FLAG (green). 
Mitochondria were stained with CMTMRos (red) and nuclei with DAPI (blue). Cells were stained at 8, 
24, or 48 h after doxycycline (Dox) induction. Bars, 10 µm. (b) Production of reactive oxygen species was 
measured in DAP-TDP-43–expressing T-REx 293 cells harvested at 0, 8, 24, and 48 h after Dox induction 
and in T-REx 293 cells harvested at 0 and 48 h after Dox treatment. The amount of reactive oxygen species 
(fluorescence intensity; arbitrary unit) per cell is relative to cells without Dox induction. Values are the 
average ± SD of three independent experiments. **P < 0.01 (unpaired t test). (c) Proliferation of T-REx 
293 cells expressing DAP-TDP-43 or its point mutants relative to that of cells without Dox induction was 
measured by cell counting. Values are the average ± SD of three independent experiments. *P < 0.05. 
**P < 0.01 (unpaired t test). (d) DAP-TDP-43-expressing T-REx 293 cells treated with ( + EtBr) or 
without EtBr (−EtBr) for 24 h were induced with Dox (+Dox) for 48 h, and numbers of cells relative to 
both −EtBr and −Dox cells were counted. **P < 0.01 (unpaired t test). The expression of DAP-TDP-43 
was examined by western blotting with anti-TDP-43 and anti-GAPDH. The inhibition of mt transcription 
by EtBr was confirmed with SYBR Gold staining of 12S mt-rRNA. (e,f) Mitochondrial proteins prepared 
from T-REx 293 cells or from DAP-TDP-43-expressing T-REx 293 cells harvested at 0, 24, and 48 h after 
Dox induction (Dox) were analysed by western blotting with the indicated antibodies (e). Intensities of the 
immunostained bands in e were quantified relative to those at 0 h of Dox induction. Only the proteins for 
which the level changed upon overexpression of TDP-43 are shown (f). Data are the mean ± SD, n = 3–5. 
*P < 0.05, **P < 0.01 (paired t test).
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the manufacturer’s instructions. Transcripts were collected by isopropanol precipitation, and purified using 
reverse-phase liquid chromatography. To synthesize biotinylated mirrorCOXI-YCNA RNA, template DNA for 
in vitro transcription was prepared. We amplified DNA fragments corresponding to mtDNA between mirror 
mt-tRNAAsn to COX I with the primer set (mirrorANCY-COXI-for/ mirrorANCY-COXI-for) using KOD neo 
plus (TOYOBO), and inserted them into the BamHI/PstI site of the pSPT19 vector (Roche) (mirrorANCY-COXI 
pSPT19). mirrorANCY-COXI pSPT19 linearlized by digesting with SmaI was used as template DNA for in vitro 
transcription. Biotin-labeled mirrorCOXI-YCNA was in vitro transcribed from the DNA template (0.06 pmol) 
in the presence of 7.5 mM of ATP, 7.5 mM of CTP, 7.5 mM of UTP, 7.5 mM GTP, 0.5 mM of biotin-UTP (Roche) 
using CUGA® 7 in vitro transcription kit (NIPPON GENE, Japan), and purified by 1% agarose gel electrophoresis 
and the subsequent gel extraction using Zymoclean Gel RNA Recovery Kit (ZYMO RESEARCH).
EMSA. Each binding reaction was performed at room temperature for 20 min. Each reaction was performed 
in 10 µl binding buffer (40 mM Tris-HCl (pH 7.4), 30 mM KCl, 1 mM MgCl2, 0.01% IGEPAL CA-630, 1 mM 
DTT, 10 µg of yeast tRNA (Ambion), 10 µg BSA, 10 ng of synthetic RNA, 200 ng of recombinant protein), and 
electrophoresed on a 6% non-denaturing polyacrylamide gel at 100 V for 50 min in 0.5× Tris borate/EDTA buffer 
(44.5 mM Tris-borate and 1 mM EDTA). The separated RNA-protein complexes were transferred to a Hybond 
N+ membrane that was dried and UV-crosslinked using the FS-1500 crosslinker (Funakoshi) at 120 mJ/cm2. The 
synthetic RNA was detected by northern blot analysis using the indicated probes.
Figure 7. TDP-43 deficiency impairs mitochondrial function and decreases intermediates of mitochondrial 
transcripts. (a) Mitochondrial membrane potential was measured by CMTMRos staining of MCF7 cells after 
knockdown of TDP-43 with siRNA1 or siRNA3. The membrane potential per concentration of total proteins of 
the siRNA-treated cells relative to that for scRNA-treated cells harvested at 72 h after treatment is shown. Values 
are the average ± SD of five independent experiments. **P < 0.01 (unpaired t test). TDP-43 level was examined 
by western blotting with the indicated antibodies. (b) Cellular ATP levels per siRNA-treated MCF7 cell were 
calculated relative to that for scRNA-treated cells. Values are the average ± SD of six independent experiments. 
**P < 0.01 (unpaired t test). (c) Activity of electron transfer complex I per concentration of total proteins was 
measured for MCF7 cells harvested at 72 h after siRNA treatment relative to that measured for MCF7 cells with 
scRNA treatment. Values are the average ± SD of three independent experiments. **P < 0.01. (d) mt-tRNA 
levels upon knockdown of TDP-43 in MCF7 cells were assessed with northern blotting. Probes are indicated 
under the figures. The intermediates of mitochondrial transcripts were indicated to the right side of the figures. 
28S rRNA stained by methylene blue served as a loading controls.
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Competition Binding Assay with synthetic RNA. Total cell lysate from 1.0 × 107 cells expressing 
DAP-TDP-43 was used for this assay. Synthetic RNA (sRNA) (1 pmol) was added to the total cell lysate and 
subjected to immunoprecipitation using anti-FLAG magnetic beads as described above. RNA isolated from 
DAP-TDP-43 complex was subjected to denaturing urea-PAGE and northern blot analysis.
Mitochondria Isolation. Mitochondria were prepared from T-REx 293 cells or 293 T cells grown in 
5 × 15 cm2 dishes. Cells washed twice with PBS were sedimented (800 × g for 5 min at 4 °C), and resuspended 
in 9 ml of ice-cold Solution A (20 mM Hepes-KOH pH7.6, 220 mM Mannitol, 70 mM Sucrose, 1 mM EDTA, 
1 mM PMSF, 2 mg/ml fatty acid free BSA). Cells were homogenized by passing ten times with a 25 G needle. 
The nuclei from this suspension were sedimented (800 × g for 10 min at 4 °C), and the centrifugation step was 
repeated for the supernatant once more. Mitochondria were sedimented from the supernatant by centrifugation 
(15,000 × g for 20 min at 4 °C), and washed once with 1 ml of Solution A. Protein concentration was measured 
using NanoDrop. For Proteinase K protection assay, the isolated mitochonaria was diluted into 1 mg/ml with 
Solution B (10 mM Hepes-KOH pH7.6, 500 mM Sucrose). 100 µg of mitochondria was treated with the indicated 
concentration of Proteinase K (Takara Bio, Osaka, Japan) for 20 min on ice. Mitochondria were treated with 0.5% 
(w/v) of Triton X-100 along with the treatment of Proteinase K for a control of Proteinase K protection assay. 
Proteinase K reaction was stopped with the addition of 1 mM PMSF, and the mitochondria were centrifuged 
(12,000 × g for 5 min at 4 °C), resuspended with SDS sample buffer, and subjected to western blot analysis.
Preparation of Mitoplast extraction. 100 µg of Mitochondria isolated from 293 T cells were resuspended 
with 500 µl of 20 mM Hepes-KOH pH 7.4, and incubated for 20 min on ice. After sedimenting mitochondria by 
centrifugation (10,000 × g for 10 min at 4 °C), pellet were washed once with Solution B, resuspended with 50 µl 
of 20 mM Hepes-KOH pH 7.4, and disrupted twice for 30 sec using Bioruptor UCD-250 (Cosmo Bio). After 
sedimenting them by centrifugation (20,000 × g for 30 min at 4 °C), the supernatants were used as a mitoplast 
extraction. Protein concentration was measured using BCA assay.
mtRNA degradation assay. mtRNA degradation assay was performed at 25 °C for 5, 10 or 30 min. Each reac-
tion was performed in 20 µl of reaction buffer (20 mM Tris-HCl (pH 7.4), 60 mM KCl, 12.5 mM MgCl2, 0.1 EDTA, 
2 mM DTT, 10% Glycerol, 10 µg mitoplast extract, 10 fmol biotinylated mirrorCOXI-YCNA RNA, 600 ng TF-fused 
protein). Reaction was stopped by the addition of 150 µl Protein-RNA extraction buffer (7 M urea, 350 mM NaCl, 
1% SDS, 10 mM Tris-HCl (pH 8.0), 10 mM EDTA, and 2% 2-mercaptoethanol), and protein or RNA in the reaction 
was purified as described previously40, 41. The eluted proteins and RNA were subjected to SDS-PAGE or northern blot 
analysis using 1.5% denaturing agarose gel. Biotinylated RNA was detected using HRP-conjugated Streptavidine.
Figure 8. Hypothetical scheme for the effect of increased TDP-43 level on mt polycistronic transcripts. 
Overexpression of TDP-43 causes an increase in TDP-43 level in mitochondria. The excess TDP-43 stabilises 
the L-strand transcript (dashed red line) by binding directly to regions corresponding to mt-tRNAPro (Pro), mt-
tRNAAsn (Asn), and mt-tRNAGln (Gln), and the resulting L-strand-derived transcript (solid red line), and then 
stabilises one of the transcripts from the H-strand (solid blue line) via complementary double-stand formation. 
The increased TDP-43 level in mitochondria thereby causes unbalanced processing the mt-transcript, resulting 
in deregulation of mitochondrial protein synthesis.
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